| Also known as |
Risperdal, Rispolept |
| Blood pressure |
Can cause orthostatic hypotension (a drop in blood pressure when standing up) |
| Chemical name |
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
| Dosage (medical) |
1 to 16 mg daily, depending on condition and patient response |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces symptoms of schizophrenia and bipolar disorder, can stabilize mood |
| Formula |
C23H27FN4O2 |
| Half-life |
20 hours (parent compound), 20-30 hours (active metabolite) |
| Hepatotoxicity |
Rare, but potential for liver enzyme elevations |
| Lab Test |
Monitoring blood levels is not typically necessary but may be performed to check drug concentrations in specific cases |
| Main action |
Dopamine and serotonin receptor antagonist |
| Raw Material |
50mg Testosterone Propionate 50mg Drostanoline Propionate 50mg Trenbolone Acetate |
| Side effects |
Weight gain, extrapyramidal symptoms (such as tremors), drowsiness, dizziness, sexual dysfunction, and others |
| Storage conditions |
Store at controlled room temperature, between 20 to 25В°C (68 to 77В°F) |
| Substance class |
Atypical antipsychotic |
| Trade name |
Risperdal, among others |
| Use in sports |
None, not applicable |
| Water Retention |
Minimal |
| Manufacturer |
INTEX PHARMA |
| Packing |
10ml vial(150 mg/ml) |
